ArticleOncoscience2022

Ikaros as a downstream mediator of BCR blockade therapy in B-cell non-Hodgkin lymphoma.

Marcelo Lima Ribeiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.